CHEST Physician
-
RSV vaccination boosts antibody titers in individuals with compromised immune systems
Rachana Krishna, MBBS, MSCR, said that while a recent study may not provide the ideal efficacy outcome data, the results are still helpful in counseling this patient population.
-
Sepsis order sets good for patients, hospital bottom lines
Automating the mundane components of care delivery allows clinicians to focus more on the nuances of individualized evaluation and personalized care.
-
Home high-flow nasal cannula therapy
Home high-flow nasal cannula therapy is a promising alternative form of respiratory support to NIV and CPAP. The treatment has been associated with a reduced number of acute exacerbations.
-
Strengthening more than just airways
Emerging research reveals that nutrition and exercise are two powerful yet underutilized tools in managing bronchiectasis.
-
Viscoelastic testing in sepsis-induced coagulopathy
SIC is a common ICU complication that clinicians are starting to identify in patients earlier through point-of-care viscoelastic testing such as rotational thromboelastometry and thromboelastography.
-
COPD program aims to close gaps in diagnosis and treatment
CHEST’s new Bridging Specialties®: Timely Diagnosis and Treatment for COPD program is focused on enhancing collaboration between PCPs and pulmonologists.
-
Novel obesity medications open door to new era in treatment of OSA
In December 2024, the FDA approved tirzepatide, a dual GIP and GLP-1 receptor agonist previously approved for type 2 diabetes and obesity, as the first prescription medication for adults with moderate to severe OSA and obesity.
-
COVID-19 immune patterns offer hope for future IPF treatment
Jose D. Herazo-Maya, MD, and colleagues are investigating a mechanism of T-cell suppression that may contribute to the development of a treatment for pulmonary fibrosis.
-
Understanding high-risk factors like PM2.5 in lung cancer
Renelle Myers, MD, FRCPC, discusses factors beyond tobacco use that clinicians should consider when screening for lung cancer, such as pollution exposure.
-
Putting women’s health front and center in lung cancer screening
CHEST President, John Howington, MD, MBA, FCCP, focuses on women’s health and the need to spread awareness about lung cancer screening among women.
